Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females

Journal of Affective Disorders

Volumn 136, Issue 3, 2012, Pages 558-566

  Shi, Yanyan ^a   Yuan, Yonggui ^b   Xu, Zhi ^b   Pu, Mengjia ^b   Wang, Congjie ^c   Zhang, Yumei ^d   Liu, Zhening ^e   Wang, Chuanyue ^f   Li, Lingjiang ^e   Zhang, Zhijun ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c Huai'An No3 People's Hospital   (China)

^d Yangzhou Wutaishan Hospital   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antidepressant; Childhood adversity; Life events; Major depressive disorder; Signal transduction pathway

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; PHOSPHOLIPASE C BETA1; PHOSPHOLIPASE C BETA2; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAMILTON SCALE; HAPLOTYPE; HUMAN; LIFE EVENTS SCALE; LIFE STRESS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ALLELES; ANTIDEPRESSIVE AGENTS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC VARIATION; HAPLOTYPES; HUMANS; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 84857371055     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.10.030     Document Type: Article

References (46)

1. D. Akin, D.H. Manier, E. Sanders-Bush, and R.C. Shelton Signal transduction abnormalities in melancholic depression The International Journal of Neuropsychopharmacology 8 2005 5 16
2. D. Amital, L. Fostick, A. Silberman, A. Silberman, M. Beckman, and B. Spivak Serious life events among resistant and non-resistant MDD patients Journal of Affective Disorders 110 2008 260 264
3. J. Balciuniene, L. Emilsson, L. Oreland, U. Pettersson, and E. Jazin Investigation of the functional effect of monoamine oxidase polymorphisms in human brain Human Genetics 110 2002 1 7
4. S. Bano, S. Akhter, and M.I. Afridi Gender based response to fluoxetine hydrochloride medication in endogenous depression Journal of the College of Physicians and Surgeons - Pakistan 14 2004 161 165
5. T.J. Barrett, and W.V. Vedeckis Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types Receptors & Signal Transduction 6 1996 179 193
6. D.P. Bemstein, and L. Fink Childhood Trauma Questionnaire. A Retrospective Self-report Manual 1998 The Psychological Corporation, Harcourt Brace & Company San Antonio
7. K.A. Berg, and W.P. Clarke Regulation of 5-HT(1A) and 5-HT(1B) receptor systems by phospholipid signaling cascades Brain Research Bulletin 56 2001 471 477
8. P. Blier, and C. de Montigny Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders Neuropsychopharmacology 21 1999 91 98
9. J.D. Bukh, C. Bock, M. Vinberg, T. Werge, U. Gether, and L.V. Kessing No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment European Neuropsychopharmacology 20 2010 327 335
10. A. Caspi, and T.E. Moffitt Gene-environment interactions in psychiatry: joining forces with neuroscience Nature Reviews Neuroscience 7 2006 583 590
11. R. Deogracias, G. Espliguero, T. Iglesias, and A. Rodriguez-Pena Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons Molecular and Cellular Neurosciences 26 2004 470 480
12. D. Dowlatshahi, G.M. MacQueen, J.F. Wang, and L.T. Young Increased temporal cortex CREB concentrations and antidepressant treatment in major depression The Lancet 352 1998 1754 1755
13. F. Dudbridge UNPHASED User Guide. MRC Biostatistics Unit, Cambridge 2007
14. R.S. Duman, G.R. Heninger, and E.J. Nestler A molecular and cellular theory of depression Archives of General Psychiatry 54 1997 597 606
15. A. El Khoury, S.H.M. Gruber, A. Mørk, and A.A. Mathé Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 2006 535 540
16. M. Errico, R.A. Crozier, M.R. Plummer, and D.S. Cowen 5-HT (7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons Neuroscience 102 2001 361 367
17. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry 23 1960 56 62
18. T. Hirai, and K. Chida Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions Journal of Biochemistry 133 2003 1 7
19. S. Horstmann, S. Lucae, A. Menke, J.M. Hennings, M. Ising, and D. Roeske Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment Neuropsychopharmacology 35 2010 727 740
20. M.J. Kaplan, and N.A. Klinetob Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression The Journal of Nervous and Mental Disease 188 2000 596 601
21. R. Keers, R. Uher, P. Huezo-Diaz, R. Smith, S. Jaffee, and M. Rietschel Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project The Pharmacogenomics Journal 11 2011 138 145
22. D.N. Klein, B.A. Arnow, J.L. Barkin, F. Dowling, J.H. Kocsis, and A.C. Leon Early adversity in chronic depression: clinical correlates and response to pharmacotherapy Depression and Anxiety 26 2009 701 710
23. S.G. Kornstein, M.M. Wohlreich, C.H. Mallinckrodt, J.G. Watkin, and D.E. Stewart Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials The Journal of Clinical Psychiatry 67 2006 761 770
24. G. Laje, and F.J. McMahon The pharmacogenetics of major depression: past, present, and future Biological Psychiatry 62 2007 1205 1207
25. L. Mandelli, E. Marino, A. Pirovano, R. Calati, R. Zanardi, and C. Colombo Interaction between SERTPR and stressful life events on response to antidepressant treatment European Neuropsychopharmacology 19 2009 64 67
26. G. Mercier, A.M. Lennon, B. Renouf, A. Dessouroux, M. Ramauge', and F. Courtin MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes Journal of Molecular Neuroscience 24 2004 207 216
27. M. Montminy Transcriptional regulation by cyclic AMP Annual Review of Biochemistry 66 1997 807 822
28. G.M. Murphy Jr.; S.B. Hollander, H.E. Rodrigues, C. Kremer, and A.F. Schatzberg Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression Archives of General Psychiatry 61 2004 1163 1169
29. C.J. Murray, and A.D. Lopez Evidence-based health policy-lessons from the Global Burden of Disease Study Science 274 1996 740 743
30. L. Musazzi, A. Mallei, D. Tardito, S.H. Gruber, A. El Khoury, and G. Racagni Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression Journal of Psychiatric Research 44 2009 511 520
31. C.B. Nemeroff, C.M. Heim, M.E. Thase, D.N. Klein, A.J. Rush, and A.F. Schatzberg Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma Proceedings of the National Academy of Sciences of the United States of America 25 2003 14293 14296
32. E.J. Nestler, R.Z. Terwilliger, and R.S. Duman Chronic antidepressant administration alters the subcellular distribution of cAMP-dependent protein kinase in rat frontal cortex Journal of Neurochemistry 53 1989 1644 1647
33. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
34. H.S. Park, M.J. Betzenhauser, J.H. Won, J. Chen, and D.I. Yule The type 2 inositol (1,4,5)-trisphosphate (InsP3) receptor determines the sensitivity of InsP3-induced Ca2 + release to ATP in pancreatic acinar cells The Journal of Biological Chemistry 283 2008 26081 26088
35. X. Qi, W. Lin, J. Li, H. Li, W. Wang, and D. Wang Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress Neurobiology of Disease 31 2008 278 285
36. A.J. Rush, I.H. Bernstein, M.H. Trivedi, T.J. Carmody, S. Wisniewski, and J.C. Mundt An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report Biological Psychiatry 59 2006 493 501
37. H.A. Sackeim The definition and meaning of treatment resistant depression The Journal of Clinical Psychiatry 62 2001 10 17
38. Y.H. Tang Hamilton anxiety scale Shanghai Psychiatry 2 1984 61 64 (In Chinese)
39. E. Tiraboschi, D. Tardito, J. Kasahara, S. Moraschi, P. Pruneri, and M. Gennarelli Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades Neuropsychopharmacology 29 2004 1831 1840
40. S.C. Tovey, S.G. Dedos, E.J. Taylor, J.E. Church, and C.W. Taylor Selective coupling of type 6 adenylyl cyclase with type 2 IP3 receptors mediates direct sensitization of IP3 receptors by cAMP The Journal of Cell Biology 183 2008 297 311
41. P. Van Eerdewegh, R.D. Little, J. Dupuis, R.G. Del Mastro, K. Falls, and J. Simon Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness Nature 418 2002 426 430
42. M.M. Weissman, R. Bland, P.R. Joyce, S. Newman, J.E. Wells, and H.U. Wittchen Sex differences in rates of depression: crossnational perspectives Journal of Affective Disorders 29 1993 77 84
43. Z. Xu, Z.J. Zhang, Y.Y. Shi, M.J. Pu, Y.G. Yuan, and X.R. Zhang Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response Journal of Psychopharmacology 2011 10.1177/0269881111414452
44. Z. Xu, Z.J. Zhang, Y.Y. Shi, M.J. Pu, Y.G. Yuan, and X.R. Zhang Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response Journal of Affective Disorders 2011 10.1016/j.jad.2011.04.011
45. M. Yamamoto-Hino, T. Sugiyama, K. Hikichi, M.G. Mattei, K. Hasegawa, and S. Sekine Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors Receptors & Channels 2 1994 9 22
46. Y.L. Zhang, and D.S. Yang Life Event Scale (LES) Chinese Journal of Mental Health 12 1999 101 106 (In Chinese)